Skip to main content
Feedback
Home

Professional Education / Transfusion

Learn.Share.Advance

Secondary Menu

  • Overview
  • Contact
  • Blog
  • EN
  • FR
  • EN
  • FR

Main menu

  • Transfusion
  • Organs and Tissues

Secondary Menu Mobile

  • Overview
  • Contact
  • Blog

Main navigation

  • COVID-19
      • COVID-19 FAQ: Information for health professionals on safety of transfused blood collected from COVID-19-vaccinated donors
      • COVID-19: FAQ for health professionals working with blood products
      • FAQ: SARS-CoV-2 antibodies in immunoglobulin products
  • Events
      • Past events
  • Courses
      • LearnTransfusion series
      • AFC-diploma program in transfusion medicine
      • Other courses and learning resources
      • BloodTechNet educational resources
      • KnowledgeInfusion
      • Transfusion Camp for nurse practitioners
        • General information
        • Module 1
        • Module 2
        • Module 3
        • Supplemental resources
      • Transfusion Camp in Rwanda 2023 - Train the Trainer Camp
      • Transfusion Camp
        • General information
        • Day 1
        • Day 2
        • Day 3
        • Day 4
        • Last year's content
  • Clinical guide
      • Chapter 1 - Vein to vein: A summary of the blood system in Canada
      • Chapter 2 - Blood components
      • Chapter 3 - Albumin
      • Chapter 4 - Immune globulin products
      • Chapter 5 - Concentrates for hemostatic disorders and hereditary angioedema
      • Chapter 6 - Donor selection, donor testing and pathogen reduction
      • Chapter 7 - Fractionated blood products and associated pathogen safety
      • Chapter 8 - Pre-transfusion testing
      • Chapter 9 - Blood administration
      • Chapter 10 - Transfusion reactions
      • Chapter 11 - Massive hemorrhage and emergency transfusion
      • Chapter 12 - Hemolytic disease of the fetus and newborn and perinatal immune thrombocytopenia
      • Chapter 13 - Neonatal and pediatric transfusion
      • Chapter 14 - Therapeutic apheresis
      • Chapter 15 - Irradiated, washed and CMV seronegative blood components
      • Chapter 16 - Preoperative autologous donation
      • Chapter 17 - Hemostatic disorders and hereditary angioedema
      • Chapter 18 - Platelet transfusion, alloimmunization and management of platelet refractoriness
      • Chapter 19 - Pathogen-reduced platelets
  • Best practices
      • Blood utilization best practices
        • Blood System Inventory Management Best Practices Guide
        • Platelet clinical best practices
      • Visual assessment guide
      • Uniform labelling
      • International Collaboration for Transfusion Medicine Guidelines (ICTMG)
      • Risk-based decision-making framework
      • Red cell antigen genotyping reports
        • Red cell antigen genotyping report: A quick glance
        • Interpreting the red cell antigen genotyping report (COMING SOON)
      • Serological best practices
        • ABO subgroups
        • Diego system: anti-Dia
        • Diego system: anti-Wra
        • Kell System: Anti-Kpa
        • Kell system: anti-Jsa
        • Lewis system: anti-Lewis
        • Lutheran system: anti-Lua
        • MNS system: anti-M
        • Rh System: Anti-V
        • Rh system: anti-Cw
        • Whole blood donors with antibodies
      • Testing and management of fetal and neonatal alloimmune thrombocytopenia
  • Publications
      • Molecular immunohematology at Canadian Blood Services: Red cell antigen genotyping
      • Paying it forward: Why we need YOU to give blood
      • Surveillance report
      • National plan for the management of shortages of labile blood components
      • Phenotype matching and storage age of blood for sickle cell patients: A review and recommendations for transfusion practice
      • Anaphylactic transfusion reactions and IgA deficiency
      • Transfusion-related acute lung injury (TRALI)
      • Emergency framework for rationing of blood for massively bleeding patients during a red phase blood shortage
      • Blood bag spiking procedure
      • Platelet product quality remains high after seven days of storage
      • A survey of Canadian MLTs’ views on continuing education in transfusion science
      • A Guide to Reporting Adverse Transfusion Reactions
      • Alternative methods of blood donor skin disinfection
      • Blood: the basics
      • Exploring the frontiers of IVIG-associated hemolysis
      • FAQ: Canadian Blood Services platelet bacterial screening
      • FAQ: Donor high titre isohemagglutinin (anti-A/anti-B) testing at Canadian Blood Services
      • FAQ: Information for health professionals on apheresis platelet psoralen-treated (APPT) and untreated apheresis platelet in PAS-E
      • FAQ: Information for health professionals on pathogen-reduced platelets
      • FAQ: Solvent detergent (S/D) treated plasma (Octaplasma)
        • Octaplasma: One-page clinical summary
      • FAQ: Whole blood, leukocytes reduced, at Canadian Blood Services
      • Impact of COVID-19 on blood donation in Canada
      • Striking the balance: protecting data privacy in research
      • Summary of adverse transfusion reactions 2017-2022
      • The importance of iron for whole blood donors: a Canadian perspective
  • Links
      • Canadian Society for Transfusion Medicine (CSTM)
      • National Advisory Committee on Blood and Blood Products
      • Provincial blood coordinating offices
      • Reference standards
      • Textbooks
      • Transfusionnews.com
      • Other links
  2. Transfusion
  4. Links

Provincial blood coordinating offices

Alberta Blood Coordinating Program

B.C. Provincial Blood Coordinating Office (PBCO)

Manitoba, Best Blood

Nova Scotia Provincial Blood Coordinating Program

Newfoundland and Labrador Provincial Blood Coordinating Program

Ontario Regional Blood Coordinating Network (ORBCoN)

Saskatchewan Provincial Blood Office

 

 

© 2021 Canadian Blood Services. All rights reserved.

  • blood.ca
  • Contact us
  • Privacy policy
  • Legal